Valuation
- Market cap
- 1,260,000
- Revenue TTM
- $0
- Net income TTM
- $-7,150,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 1,235,410
- Avg volume
- 777,756
- Day's range
- $0.53 – $0.75
- Shares out
- 2,371,000
- Stochastic %K
- 36%
- Beta
- 1.41
- Analysts
- Hold
- Price target
- $3.25
Company profile
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 619 941 0360
- Website
- https://www.aethlonmedical.com
- Address
- 11555 Sorrento Valley Road, Suite 203, San Diego, United States
Latest news
No headlines yet.
